U.S. markets closed

American Green, Inc. (ERBB)

Other OTC - Other OTC Delayed Price. Currency in USD
0.0012-0.0001 (-4.17%)
At close: 03:45PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0012
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0011 - 0.0012
52 Week Range0.0007 - 0.0021
Avg. Volume8,857,111
Market Cap34.199M
Beta (5Y Monthly)1.30
PE Ratio (TTM)N/A
EPS (TTM)-0.1460
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for ERBB

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    Analyst Report: Johnson & JohnsonJohnson & Johnson is the world's largest and most diverse healthcare firm. Three divisions make up the firm: pharmaceutical, medical devices and diagnostics, and consumer. The drug and device groups represent close to 80% of sales and drive the majority of cash flows for the firm. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. The device segment focuses on orthopedics, surgery tools, vision care, and a few smaller areas. The last segment of consumer focuses on baby care, beauty, oral care, over-the-counter drugs, and women’s health. The consumer group is being divested in 2023 under the new name Kenvue. Geographically, just over half of total revenue is generated in the United States.
    Fair Value
    Economic Moat
    9 hours agoMorningstar
View more
  • GlobeNewswire

    American Green (OTC:ERBB) Issues Strategic Corporate Overview

    Looking to Further Expand Its Cannabis Business in 2023 PHOENIX, AZ, Feb. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – American Green (ERBB: OTC) In May of 2022, American Green purchased the approximate 40,000 sf building now known as American Green’s “Cypress Chill” cannabis facility located at 2325 W. Cypress St. Phoenix, AZ. for $3.75MM. American Green announced today that The Company is, again, looking to expand its cannabis grow business in 2023. “American Green is looking at a potential

  • GlobeNewswire

    American Green (OTC:ERBB) Signs $12 Million Dollar Non-Binding Letter of Intent for Funding of its Cypress Chill Cannabis Grow Building

    PHOENIX, AZ, Feb. 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Today American Green (ERBB: OTC) announced that it has signed a non-binding letter of intent for $12,000,000 with a private equity firm to fund the completion of the build-out at its “Cypress Chill” grow building that it purchased in May of 2022 for $3.75MM. The company will continue to provide the documentation required by the lender so it can get through the loan application process. American Green will keep looking for the best

  • NewMediaWire

    American Green (OTC:ERBB) Receives Equipment Lease Funding for its 40K s.f. Cypress Chill Cannabis Grow

    Today American Green (ERBB:OTC) announced that it has received equipment lease funding for the 2 custom made AC adiabatic fluid coolers (each weighing over 13,500 lbs) delivered last year. This HVAC equipment is on site and our plans call for it to be installed at the Cypress Chill cannabis grow operation as soon as the structural steel is installed to support it. Equipment funding was provided by Global Financial Leasing Services LLC.